RIVA-IRBESARTAN
Identification of Riva-Irbesartan
| No description |
Google image searchProduct monograph
Active ingredient
irbesartan, 300 MG
DIN: 02524759
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 08-JUN-2023
ATC:
- C09 — AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM (ATC, ATC/DDD, )
- C09C — ANGIOTENSIN II ANTAGONISTS, PLAIN (ATC, ATC/DDD)
- C09CA — Angiotensin II antagonists, plain (ATC, ATC/DDD)
- C09CA04 — IRBESARTAN (ATC/DDD)
Reference brand drug: Avapro
Pharmaceutical standard: MFR
